We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Patient-Specific Implant Techniques Could Reduce Stroke Risk in Patients with LVADs

By HospiMedica International staff writers
Posted on 16 Jun 2025

For individuals with advanced heart failure, left ventricular assist devices (LVADs) can be life-saving. More...

These implantable devices enhance blood circulation throughout the body and are often the final therapeutic option available for patients with severe heart failure. With over 14,000 people currently using them and heart failure affecting 26 million individuals worldwide, the use of LVADs is expected to rise. However, they are not without risks. Compared to the general population, people with LVADs face an 11% to 47% greater chance of developing blood clots that may travel to the brain and cause a stroke. The reason why some LVAD patients experience strokes while others do not remains unclear. A new study now points to hemodynamics—how blood flows through the body—as a possible explanation.

The body depends on a steady supply of oxygen-rich blood to function properly. Heart failure arises when the heart is no longer able to pump enough blood to meet the body's needs. Normally, during each heartbeat, the heart’s left ventricle contracts and sends blood into the arteries, delivering oxygen and nutrients to organs, muscles, and bones. In heart failure, the left ventricle weakens and loses its efficiency. An LVAD, which connects directly to the heart, bypasses this ventricle and pumps blood straight into the aorta, the body’s main artery. While LVADs can prolong and improve life, they also raise the likelihood of blood clots forming. When blood flow slows or stagnates—especially in areas like the left ventricle—it can lead to clot formation. These clots can then travel through major arteries, with the vessels supplying the brain being among the most critical. If a clot becomes lodged there, it can block or reduce blood flow to the brain, leading to a stroke.

Applying engineering principles such as fluid dynamics to medical questions can provide perspectives that traditional diagnostic tools may overlook. A team of engineers from the University of Colorado Boulder (Boulder, CO, USA), along with collaborators, conducted a study to investigate whether differences in blood flow among LVAD users could account for who develops strokes. They studied 12 LVAD patients—six who had experienced strokes after implantation and six who had not. Using detailed imaging data of the aorta, surrounding vessels, and the attached LVAD component, they constructed 3D digital models or “digital twins” of each patient. The team also incorporated each individual's clinical data, including heart rate and blood pressure, into the models. These simulations offered new insights into stroke mechanisms. The digital twins enabled the researchers to estimate how blood moved through each person’s aorta and to simulate how flow patterns might have looked before the LVAD implantation.

Their analysis revealed differences in blood flow between those who had strokes and those who did not—both before and after receiving their LVADs. They discovered that the LVADs altered blood flow in each case, creating a forceful “jet” of blood that entered the aorta at an angle different from the natural flow produced by the heart. These altered flow dynamics could help explain why some patients are more susceptible to stroke. For example, some flow patterns may promote blood stagnation in specific areas, increasing the likelihood that platelets will adhere to protein networks in the blood and form clots. The study’s findings may lead to better treatment strategies and outcomes for patients with heart failure. With this knowledge, clinicians could tailor LVAD implantation procedures and post-operative monitoring to each patient. They might also be able to assess stroke risk more accurately and deliver more personalized treatments.

“Knowledge gained from this study can help us develop patient-specific implant techniques to reduce the likelihood of stroke in patients with durable LVADs,” said Professor Jay Pal, a co-author of the study.

Related Links:
CU Boulder


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Diagnostic Ultrasound System
DC-80A
New
Antimicrobial Mat
MULTIMAT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.